海格投资 HTGC 深沪

已收盘 10-10 16:00:00 美东时间

16.70

-0.360

-2.11%

华盛通

立即下载

最高17.19
今开17.11
成交量 317.72万股
最低 16.625
昨收 17.06
总市值 29.23亿
52周最高 20.63
市盈率 ^静 10.37
换手率 1.82%
52周最低 14.71
委比 -66.67%
总股本 1.75亿
历史最高 20.63
量比 1.88
振幅 3.31%
历史最低 -4.31
每手 1
风险率 2.16%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元

10-10 11:36
Piper Sandler Maintains Overweight on Hercules Capital, Lowers Price Target to $20.5

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and lowers the price target from $21 to $20.5.

10-09 21:57
Akero Therapeutics Settles Loan with Hercules Capital

Akero Therapeutics ( ($AKRO) ) has issued an update. On September 23, 2025, Ake...

09-30 04:40
uniQure Secures $175 Million Loan Amendment

The latest announcement is out from uniQure ( ($QURE) ). On September 22, 2025,...

09-25 16:20
What's Going On With UniQure Stock Wednesday?

UniQure N.V. (NASDAQ:QURE) shares are trading higher Wednesday after the company announced positive topline results from Phase I/II study of AMT-130 in patients with Huntington's Disease.

09-25 01:57
美股异动 | 亨廷顿病关键研究取得积极进展 uniQure(QURE.US)暴涨超186%

周三，uniQure(QURE.US)暴涨超186%，创四年新高，报39.11美元。

09-24 22:29
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial

UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 million financing for launch readiness.

09-24 22:23
uniQure Refinances $50M Debt And Gains Access To Additional $125M Non-Dilutive Funding From Hercules Capital

Term of current $50 million debt outstanding extended from January 2027 to October 2030Additional $100 million available subject to regulatory and financial milestonesAdditional $25 million available subject to Hercules'

09-24 19:12
Senseonics Holdings Memorandum Of Understanding To Transition All Commercialization And Distribution Of Eversense 365 And Future Products From Ascensia Diabetes Care; Non-dilutive Debt Facility Expanded Up To $100M With Hercules Capital To Fund Commercial Organization

CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be appointed Chief Commercial OfficerNon-dilutive debt facility expanded up to $100 million with Hercules Capital to fund

09-04 05:22
Heron Therapeutics announces capital restructuring to support growth

Heron Therapeutics (NASDAQ:HRTX) Friday reported the completion of a comprehensive capital restructuring designed to enhance the company's financial flexibility, reduce total debt, and support long-te...

08-08 20:41

派息除权日	每股总股息	派息日期
2025-08-12	0.47	2025-08-19
2025-05-13	0.47	2025-05-20
2025-02-26	0.47	2025-03-05
2024-11-13	0.48	2024-11-20
2024-08-13	0.48	2024-08-20
2024-05-13	0.48	2024-05-21
2024-02-27	0.48	2024-03-06
2023-11-14	0.48	2023-11-22
2023-08-17	0.48	2023-08-25
2023-05-15	0.47	2023-05-23
2023-03-01	0.47	2023-03-09
2022-11-09	0.51	2022-11-17
2022-08-08	0.50	2022-08-16
2022-05-16	0.48	2022-05-24
2022-03-08	0.48	2022-03-16
2021-11-09	0.40	2021-11-17
2021-08-10	0.39	2021-08-18
2021-05-11	0.39	2021-05-19
2021-03-05	0.37	2021-03-15
2020-11-06	0.34	2020-11-16
2020-08-07	0.32	2020-08-17
2020-05-13	0.32	2020-05-21
2020-02-28	0.40	2020-03-09
2019-11-07	0.35	2019-11-18
2019-08-09	0.34	2019-08-19
2019-05-10	0.33	2019-05-20
2019-03-01	0.31	2019-03-11
2018-11-08	0.33	2018-11-19
2018-08-10	0.31	2018-08-20
2018-05-11	0.31	2018-05-21
2018-03-02	0.31	2018-03-12
2017-11-10	0.31	2017-11-20
2017-08-10	0.31	2017-08-21
2017-05-11	0.31	2017-05-22
2017-03-02	0.31	2017-03-13
2016-11-09	0.31	2016-11-21
2016-08-11	0.31	2016-08-22
2016-05-12	0.31	2016-05-23
2016-03-03	0.31	2016-03-14
2015-11-12	0.31	2015-11-23
2015-08-13	0.31	2015-08-24
2015-05-14	0.31	2015-05-25
2015-03-10	0.31	2015-03-19
2014-11-13	0.31	2014-11-24
2014-08-14	0.31	2014-08-25
2014-05-08	0.31	2014-05-19
2014-03-06	0.31	2014-03-17
2013-11-14	0.31	2013-11-25
2013-08-09	0.28	2013-08-20
2013-05-10	0.27	2013-05-21
2013-03-07	0.25	2013-03-19
2012-11-09	0.24	2012-11-21
2012-08-15	0.24	2012-08-24
2012-05-16	0.24	2012-05-25
2012-03-08	0.23	2012-03-15
2011-11-09	0.22	2011-11-29
2011-08-11	0.22	2011-09-15
2011-05-11	0.22	2011-06-23
2011-03-08	0.22	2011-03-24
2010-11-08	0.20	2010-12-17
2010-08-10	0.20	2010-09-17
2010-05-10	0.20	2010-06-18
2010-02-17	0.20	2010-03-19
2009-12-22	0.04	2009-12-30
2009-10-16	0.30	2009-11-23
2009-08-12	0.30	2009-09-14
2009-05-13	0.30	2009-06-15
2009-02-19	0.32	2009-03-30
2008-11-12	0.34	2008-12-15
2008-08-13	0.34	2008-09-15
2008-05-14	0.34	2008-06-16
2008-02-13	0.30	2008-03-17
2007-11-14	0.30	2007-12-17
2007-08-14	0.30	2007-09-17
2007-05-14	0.30	2007-06-18
2007-02-14	0.30	2007-03-19
2006-11-02	0.30	2006-12-01
2006-07-27	0.30	2006-08-28
2006-04-06	0.30	2006-05-05
2006-01-04	0.30	2006-01-27
2005-10-28	0.03	2005-11-17

公司名称	海格投资
行业分类	资产管理
业务描述	Hercules is a non-bank lender to venture capital-backed companies at all stages of development in a broadly diversified variety of technology, life sciences, and sustainable and renewable technology industries. With over a decade of experience in venture debt, Hercules is uniquely positioned to create innovative financing solutions that perfectly fit within a company's existing capital structure and map to its business objectives. Recognized as the industry leader, Hercules understands the flexibility these types of companies need and has the experience to work closely with them, even through challenging times, to help them reach critical milestones. Hercules' deep sector expertise, geographic presence, and strong capital base have made Hercules the lender of choice for more than 480 innovative companies.

海格投资 HTGC 深 沪

16.70

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

海格投资 HTGC 深沪